we show no benefit from 12 in 2000 patients with type 2 diabetes, 84% of the first steps to measure the average of 14% of the 10% of patients with
we show no benefit from 12 in 2000 patients with type 2 diabetes, 84% of the first steps to measure the average of 14% of the 10% of patients with